BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1594 related articles for article (PubMed ID: 28652656)

  • 21. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
    Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
    Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.
    Hosomi S; Yamagami H; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    J Crohns Colitis; 2018 Jan; 12(1):87-95. PubMed ID: 28961693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity.
    Maione F; Giglio MC; Luglio G; Rispo A; D'Armiento M; Manzo B; Cassese G; Schettino P; Gennarelli N; Siciliano S; D'Armiento FP; De Palma GD
    Tech Coloproctol; 2017 Jul; 21(7):531-540. PubMed ID: 28674950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
    Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
    J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
    Menesy A; Hammad M; Aref S; Abozeid FAM
    BMC Gastroenterol; 2024 Apr; 24(1):135. PubMed ID: 38622545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
    Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
    Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Mertz Nielsen A
    J Crohns Colitis; 2015 Aug; 9(8):625-32. PubMed ID: 25956537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.
    Theede K; Holck S; Ibsen P; Ladelund S; Nordgaard-Lassen I; Nielsen AM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1929-36.e1. PubMed ID: 26051392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
    Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ
    Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
    Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
    Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Invasive Assessment of Inflammation and Treatment Response in Patients with Crohn's Disease and Ulcerative Colitis using Contrast-Enhanced Ultrasonography Quantification.
    Socaciu M; Ciobanu L; Diaconu B; Hagiu C; Seicean A; Badea R
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):457-65. PubMed ID: 26697572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
    Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.